NYSE:PTN

Palatin Technologies Stock News

etoro logo Buy PTN
*Your capital is at risk
$11.77
+0.0500 (+0.427%)
At Close: Jun 22, 2026

Palatin Technologies, Inc. (PTN) Reports Q3 Loss, Misses Revenue Estimates

12:45pm, Tuesday, 17'th May 2022 Zacks Investment Research
Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 0% and 62.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 0% and 62.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWS WIRES

PhaseBio Pharmaceuticals (PHAS) Reports Q1 Loss, Misses Revenue Estimates

11:15am, Monday, 16'th May 2022 Zacks Investment Research
PhaseBio Pharmaceuticals (PHAS) delivered earnings and revenue surprises of 65.67% and 98%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology BridgeBio Pharma Inc 

Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Tops Revenue Estimates

12:15pm, Thursday, 12'th May 2022 Zacks Investment Research
Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of -50% and 7.12%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stoc
CRANBURY, N.J. , May 11, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2022 operating results on Tuesday, May 17, 2022, before the o

Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates

12:45pm, Tuesday, 10'th May 2022 Zacks Investment Research
Intra-Cellular (ITCI) delivered earnings and revenue surprises of 16.13% and 5.16%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Berkeley Lights, Inc. (BLI) Reports Q1 Loss, Lags Revenue Estimates

09:15pm, Monday, 09'th May 2022 Zacks Investment Research
Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -3.23% and 1.60%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Curis (CRIS) Reports Q1 Loss, Misses Revenue Estimates

10:05pm, Thursday, 05'th May 2022 Zacks Investment Research
Curis (CRIS) delivered earnings and revenue surprises of -5.88% and 6.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Posters highlight Palatin's ocular research and PL9643 Phase 2 clinical data CRANBURY, N.J. , May 2, 2022 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN), a biopharmaceutic
Popular Reddit penny stocks to watch under $1. The post Best Penny Stocks Today? 4 To Buy For Under $1 According To Reddit appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Popular Reddit penny stocks to watch under $1. The post Best Penny Stocks Today?

Repare Therapeutics Inc. (RPTX) Stock Jumps 9.1%: Will It Continue to Soar?

12:24pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Repare Therapeutics Inc. (RPTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in t
Palatin Technologies Inc. (AMEX:PTN) shares, rose in value on Friday, 03/11/22, with the stock price down by -4.12% to the previous day’s close as strong demand from buyers drove the stock to $0.38. Actively observing the price movement in the last trading, the stock closed the session at $0.40, falling within a range of $0.38 … In 2022, Will Palatin Technologies Inc. (AMEX: PTN) Be Bullish Or Bearish? Read More »
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE